Search Results
May 27, 2025, 08:00 ET 6.9 MW Brooklyn Project in Development by SolarBank in Nova Scotia, Canada
earn credits on their electric bill and save $0.02/kWh from the electricity that is generated by a project. So far, the NS CSP has only granted three CSP Contracts, totalling 7.05MW AC. AI Renewable won two Contracts, size of 6.5MW AC, as a result of the Company's solar development
More news about: SolarBank Corporation
May 26, 2025, 10:01 ET Gastops and Leeway Marine Advance Innovative Engine Oil Monitoring System with Successful Field Testing
DARTMOUTH, NS, May 26, 2025 /PRNewswire/ - Gastops is pleased to announce the successful completion of a full season of field testing of an innovative online fluid
More news about: Gastops Ltd.
May 26, 2025, 10:01 ET Gastops and Leeway Marine Advance Innovative Engine Oil Monitoring System with Successful Field Testing
DARTMOUTH, NS, May 26, 2025 /PRNewswire/ -- Gastops is pleased to announce the successful completion of a full season of field testing of an innovative online
More news about: Gastops Ltd.
May 26, 2025, 03:22 ET Cosmic CRF Limited Reports H2 & FY25 Performance Highlights
a significant 41% increase from 32,000 MTPA in FY24 with the addition of one more 6000 sq. ft shed extensionNS Engineering Projects Private Limited Capacity (Subsidiary) has reached installed capacity of 65,000 MT in FY25 in line
More news about: Cosmic CRF Limited
May 22, 2025, 09:27 ET CytoSorbents Therapy Significantly Reduces Bleeding in Urgent CABG Patients on Ticagrelor in New Data Presented at EuroPCR 2025
p<0.001) and re-operations for bleeding (4% vs. 9.6% control, p=0.02). Mortality at 30 days was not different between the 2 groups (4.4% vs. 6.5%, p=ns). Importantly, there were no device deficiencies or device-related adverse events reported by participating centers, underscoring the ease and safety
More news about: Cytosorbents Corp
May 21, 2025, 09:00 ET BEYBLADE X World Championship Takes Over Walmart Stores as Fans Battle for the Ultimate Ticket to Tokyo and a Spot in the Final Tournament
Canada)July 5: Dartmouth (90 Lamont Terrace Dartmouth, NS B3B 0B5, Canada)July 5: Orleans (3900 Innes Rd. Orléans, ON K1W 1K9,
More news about: ADK Emotions NY, Inc.
May 20, 2025, 20:44 ET ASUS and Republic of Gamers Announces Newly Available NVIDIA GeForce RTX 5060 equipped Strix G, Zephyrus, and TUF Gaming laptops
FA608UM - NS76 FA608UM - NS73
More news about: ASUS Computer International
May 15, 2025, 14:19 ET World's First Patient Treated with Personalized CRISPR Gene Editing Therapy at Children's Hospital of Philadelphia
supported by grants from the National Institutes of Health Somatic Cell Genome Editing Program (U01TR005355, U19NS132301), as well as additional National Institutes of Health grants (R35HL145203, U19NS132303, DP2CA281401, P01HL142494). In-kind contributions were made by Acuitas Therapeutics, Integrated DNA Technologies,
More news about: Children's Hospital of Philadelphia
May 14, 2025, 07:13 ET FDA Accepts Biologics License Application for Mucopolysaccharidosis II Treatment
www.regenxbio.com. About NS Pharma, Inc.NS Pharma, Inc., is a wholly owned subsidiary of Nippon Shinyaku Co., Ltd. NS Pharma is a registered trademark of the Nippon Shinyaku Co., Ltd. For more information, please visit
More news about: NS Pharma, Inc.
May 13, 2025, 14:36 ET Prof. Mike Chans Vision der Präzisionsmedizin wird durch eine bahnbrechende Humanzytologie-Studie bestätigt, die über 400 verschiedene Zelltypen kartiert, mit besonderem Schwerpunkt auf dem Gehirn
neurodegenerativen Störungen und zur Wiederherstellung des Gedächtnisses. Quellen: [1] Chan MKS, Jambo SA, Jumat MI, Landa F, Saili NS, et al. Human Cytology: Classification and Quantitative Cell Landscape with Numbers, Types and Functional Diversity. J Stem Cell Res. 6(1):1-42.
More news about: European Wellness Biomedical Group
May 13, 2025, 07:05 ET REGENXBIO Announces FDA Acceptance and Priority Review of the BLA for RGX-121 for MPS II
announced in January 2025, following potential FDA approval, RGX-121 will be commercialized by NS Pharma, Inc., a wholly-owned subsidiary of Nippon Shinyaku, in the U.S. Approval of RGX-121 could result in receipt of a Priority Review Voucher (PRV).
More news about: REGENXBIO Inc.
May 13, 2025, 03:40 ET 里程碑式人類細胞學研究繪出超400種細胞圖譜（聚焦大腦），驗證了陳革成教授的精準醫療願景
Group)始終走在精準再生醫學的最前沿。借助針對特定器官和大腦的前體干細胞靶向療法，該集團可為肝臟疾病、心臟疾病、神經退行性疾病以及記憶恢復等問題提供個性化治療方案。 參考文獻： [1] Chan MKS, Jambo SA, Jumat MI, Landa F, Saili NS, et al. Human Cytology: Classification and Quantitative Cell Landscape with Numbers, Types and Functional Diversity. J Stem Cell Res. 6(1):1-42.
More news about: European Wellness Biomedical Group
May 13, 2025, 03:15 ET La vision de la médecine de précision du professeur Mike Chan est validée par une étude cytologique humaine historique qui cartographie plus de 400 types cellulaires distincts, en particulier dans le cerveau.
troubles neurodégénératifs et la restauration de la mémoire. Références : [1] Chan MKS, Jambo SA, Jumat MI, Landa F, Saili NS, et al. Human Cytology: Classification and Quantitative Cell Landscape with Numbers, Types and Functional Diversity. J Stem Cell Res. 6(1):1-42.
More news about: European Wellness Biomedical Group
May 13, 2025, 00:45 ET Estudio de citología humana que mapeó más de 400 tipos de células distintas
cardíacas, trastornos neurodegenerativos y recuperación de la memoria. Referencias: [1] Chan MKS, Jambo SA, Jumat MI, Landa F, Saili NS, et al. Human Cytology: Classification and Quantitative Cell Landscape with Numbers, Types and Functional Diversity. J Stem Cell Res. 6(1):1-42.
More news about: European Wellness Biomedical Group
May 12, 2025, 04:11 ET Prof. Mike Chan's Precision Medicine Vision Validated by Landmark Human Cytology Study Mapping Over 400 Distinct Cell Types - with Special Focus on the Brain
conditions, neurodegenerative disorders, and memory restoration. References: [1] Chan MKS, Jambo SA, Jumat MI, Landa F, Saili NS, et al. Human Cytology: Classification and Quantitative Cell Landscape with Numbers, Types and Functional Diversity. J Stem Cell Res. 6(1):1-42.
More news about: European Wellness Biomedical Group
May 08, 2025, 11:30 ET Glen-Gery Showcases Brick Innovations, Design Trends and Architect Collaborations at the AIA Conference on Architecture & Design 2025 (AIA25)
while its rugged, handcrafted quality speaks to the raw beauty of the material. NEW! SK1NSManufactured in Italy by San Selmo, the SK1NS collection combines terracotta with contemporary ceramic techniques. The terracotta cladding features seven
More news about: Glen-Gery
May 07, 2025, 08:00 ET BioVaxys and Sona Nanotech Enter Research Collaboration
VANCOUVER, BC and HALIFAX, NS, May 7, 2025 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys")
More news about: BioVaxys Technology Corp.
May 01, 2025, 06:30 ET NEVADA KING INTERCEPTS 1.11 G/T AUEQ OVER 25M AT SILVER PARK AND CONFIRMS NEW DISTRICT-SCALE POTENTIAL FOR ATLANTA-STYLE MINERALIZATION
of Atlanta South to the west-northwest, approximately 3km past SPW, and is rooted in Paleozoic basement rock (Figure 9). CSAMT data indicate multiple NS structures cutting through the target areas as well as oblique crossing structures, and it is at the intersection of these structures where numerous
More news about: Nevada King Gold Corp.
Apr 30, 2025, 13:10 ET Preclinical Study from Children's Hospital of Philadelphia Highlights Innovative Approach to Replacing Brain Cells in the Treatment of Leukodystrophies
for Krabbe Research (P4KR), the University of Pittsburgh Brain Institute internal funding, NIH (DP5OD036159), NIH (R01-NS-120960), Klingenstein-Simons Fellowship in Neuroscience, the Paul Allen Frontiers Group and Children's Hospital of Philadelphia K readiness award. The
More news about: Children's Hospital of Philadelphia
Apr 30, 2025, 09:00 ET JediCare Medical has announced successful completion of its first-in-human feasibility study of the world's first-of-its-kind Pulmonary Nodule Percutaneous Sphere Resection
follow up showed no recurrence, preserved lung function (FEV1: 2.68 before procedure vs. 2.64 three-months post procedure), and substantial ease of Ms. N's anxiety. "Conventional minimally invasive surgeries for pulmonary nodules today, including thoracoscopic wedge resection, segmentectomy, and lobectomy,
More news about: JediCare Medical Technology Co., Ltd.
Apr 29, 2025, 11:00 ET Eco Material Opening Queens Terminal to Bring 50,000 Tons of Low Carbon Cement Replacement Products Into New York City Metro Annually
the United States. New York & Atlantic Railway connects with C.P., CSX, NYNJ, NS, and P.W. For more information about New York & Atlantic Railway, please visit
More news about: Eco Material Technologies Inc
Apr 29, 2025, 09:00 ET Abbott lança teste rápido Bioline™ Dengue Duo (ponta de dedo) no Brasil
Nova solução de testagem abrange os quatro sorotipos da dengue e permite detectar o antígeno NS1 e os anticorpos IgG e IgMTeste fornece resultados em até 20 minutos e pode ser realizado em farmácias e clínicasEste é o sétimo teste de diagnóstico que a Abbott lança
More news about: Abbott
Apr 28, 2025, 07:00 ET alphaMountain AI Releases aM Intelligence™ to Accelerate Web Threat Investigation and Enrichment
intelligence for any domain or IP address including: DGA Probability – likelihood that a domain was generated by an algorithmDNS – A, AAAA, NS, MX, TXT, DMARC, DKIMGeoIP – geolocation (coordinates) of resolved IPsImpersonation – list of possible impersonated domainsPopularity
More news about: alphaMountain AI
Apr 22, 2025, 09:00 ET AI Meets QI: Densitas and TungstenQI Launch Joint Continuous Quality Improvement Initiative
HALIFAX, NS, April 22, 2025 /PRNewswire/ - Densitas®, a global leader in artificial intelligence solutions for breast cancer screening, and TungstenQI Partners,
More news about: Densitas Inc.
Apr 21, 2025, 07:13 ET FDA Grants Orphan Drug Designation to NS-229 for the Treatment of Eosinophilic Granulomatosis with Polyangiitis
JAK1," explained NS Pharma Vice President, Research & Development, Takeshi Seita. "Our therapy has been designed to target this specific enzyme." A Phase 2 global study of NS-229 is being conducted by Nippon Shinyaku and NS Pharma. About NS Pharma, Inc.NS
More news about: NS Pharma, Inc.